WA-KYMETA
23.3.2021 14:02:14 CET | Business Wire | Press release
Kymeta (www.kymetacorp.com ), the communications company making mobile global, and Kepler Communications (www.kepler.space ) announced today the successful demonstration of the Kymeta u8 Terminal with LEO satellite acquisition , tracking and throughput measurements, during extreme cold weather temperatures. The collaboration with Kepler supports Kymeta’s goal to develop solutions that are future proof with a clear LEO upgrade path and compatible with growing mega constellations.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210323005226/en/
In 2020, Kepler was selected for an extended u8 beta trial to capture the extended Northern winter in Inuvik, Canada. Frequent revisit times from the Kepler LEO satellites combined with the local environment of unprotected cold weather, snow, and ice provided a unique testing opportunity for the latest Kymeta technology. Results have demonstrated a significant increase in performance with lower latency, enhanced look angles and speeds that are approaching 10X faster than earlier products with higher throughput and total data passed.
The u8 system is designed to work down to -40o C. During testing, Kymeta and Kepler were able to update software facilitating the testing of new algorithms in real time. Updates included capabilities of on-board FPGA-based tracking receivers, which allowed for usage of channels more than 2 times larger than previous demonstrations.
Testing results exceeded expectations during these cold weather trials with average uplink and downlink speeds of 100 Mbps, providing the ability to transfer more than two gigabytes of data with each pass. Initial testing was completed using linear polarization on the u8 – in a future software upgrade the addition of circular polarization support will lead to additional increases in data transfer speeds.
“Kepler has been a great trial partner because they are agile and able to make adjustments for optimized performance at the same time we are adjusting the u8 terminal,” said David Harrower, Senior Vice President of Global Sales at Kymeta. “Many of our customers are interested in compatibility with LEO satellite services, and this testing helps ensure the longevity of the u8 and Kymeta Connect as well as offer a solution that takes advantage of the increased utility of LEO satellites.”
"The performance of the Kymeta u8 with Kepler's Global Data Service has exceeded our expectations," said Wen Cheng Chong, Kepler's CTO and Co-Founder. "Our recent testing and development efforts demonstrated not only the ability to move many more gigabytes of data than expected with each pass, but also the u8's ability to operate in polar environments, where many of Kepler's early adopters operate. With Kepler's recently increased capacity the u8 can serve customers globally, pole-to-pole and all points in between."
In January, Kepler launched 8 new satellites via SpaceX’s first dedicated SmallSat Rideshare Program. On March 22nd , Kepler launched an additional two satellites via the Soyuz-2, expanding its active constellation to 15 satellites in total. An additional launch is planned for June. Kymeta believes the collaboration with Kepler and further testing is instrumental to providing reliable connectivity and superior benefits to customers.
Kymeta next-generation solutions are built for mobility and designed specifically for the needs of global defense agencies, government, public safety, and commercial customers. Through the launch of the u8 and Kymeta Connect, the company has meaningfully increased antenna throughput and reduced the total cost of ownership. Its products offer a breakthrough in performance, ease of use, and hybrid satellite-cellular connectivity services.
About Kymeta
Kymeta is unlocking the potential of broadband satellite connectivity, combined with cellular networks, to satisfy the overwhelming demand for comms on the move and making mobile global. Lepton Global Solutions, a Kymeta company, hosts the company’s satellite connectivity solutions and offers unique, complete, and turnkey bundled solutions to the market based on best-in-class technologies and tailored customer-centric services that meet and exceed customer mission requirements. These solutions in tandem with the company’s flat-panel satellite antenna, the first of its kind, and Kymeta Connect™ services provide revolutionary mobile connectivity on satellite and hybrid satellite-cellular networks to customers around the world. Backed by U.S. and international patents and licenses, the Kymeta terminal addresses the need for lightweight, slim, and high-throughput communication systems that do not require mechanical components to steer toward a satellite. Kymeta makes connecting easy – for any vehicle, vessel, or fixed platform.
Kymeta is a privately held company based in Redmond, Washington.
For more information, visit kymetacorp.com .
About Kepler Communications Inc.
Kepler is a satellite telecommunications provider based in Canada, backed by Costanoa Ventures, IA Ventures and other leading investors. Kepler’s mission is to connect people and things Everywhere, on earth and beyond. To this end, Kepler will build an in-space telecommunications network through an incremental deployment of products and technologies. The first to launch and operate a Ku-band satellite service in Low Earth Orbit, Kepler has expanded its capabilities with the successful commissioning of a cubesat production facility at their Toronto headquarters, from which the GEN 1 satellites are being delivered.
For more information, visit www.kepler.space and @KeplerComms.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210323005226/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Netceed Strengthens Board with Global Infrastructure and Technology Leaders1.4.2026 14:00:00 CEST | Press release
Netceed, a global leader in delivering supply chain solutions across broadband, data center and energy infrastructure, today announced the appointment of Franck Bruel, Jan Frykhammar and Stacey Thompson to advise as strategic advisors to its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260401045867/en/ Franck Bruel Following the recently announced recapitalization of the Netceed Group and under the chairmanship of Rajeev Suri, the company is strengthening its Board with globally recognized leaders across telecommunications infrastructure, industrial distribution, energy infrastructure and hyperscale technology. Collectively, the new appointees bring decades of leadership experience across some of the world’s most influential infrastructure and technology companies, reflecting Netceed’s ambition to play a leading role in the next generation of global digital, AI and energy infrastructure. Rajeev Suri, Ch
Vertex Announces US FDA Approval for Label Extensions of ALYFTREK® and TRIKAFTA®, Expanding Availability of These Medicines to ~95% of All People With CF in the United States1.4.2026 13:30:00 CEST | Press release
-With this expansion, any variant that results in production of CFTR protein is now included in the indication for ALYFTREK and TRIKAFTA, reinforcing the impact these medicines have, regardless of the location of the variant in the CFTR protein--Approximately 800 more people with CF in the US are now eligible for a CFTR modulator for the first time- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved expanded use of ALYFTREK® (vanzacaftor/tezacaftor/ivacaftor) for the treatment of people with cystic fibrosis (CF) ages 6 and older with a variant in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that is either responsive based on clinical and/or in vitro data or results in production of CFTR protein. Additionally, the U.S. FDA has also expanded the indication statement for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in patients ages 2 and older. This label expansion was supported b
Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer1.4.2026 13:30:00 CEST | Press release
A Landmark Registrational Study Aiming to Redefine Outcomes in MSS mCRC Which Represents Approximately 95% of Metastatic Colorectal Cancer CasesColorectal Cancer Has Become the Leading Cause of Cancer-related Death in Adults Under Age 50 Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that the first patient has been enrolled in the landmark global phase 3 BATTMAN (CO.33) trial (NCT07152821). This study is evaluating Agenus’ immunotherapy combination of botensilimab (BOT) plus balstilimab (BAL) versus best supportive care in patients with refractory, unresectable microsatellite stable (MSS)/mismatch repair proficient (pMMR) metastatic colorectal cancer (mCRC), a population long considered resistant to immunotherapy. This study is being conducted as a cooperative group trial led by the Canadian Cancer Trials Group (CCTG) from Canada and run across Canada, France, Australia and New Zealand. More than 100 sites will participate across the academic cooper
Klarna Agrees to $1.7 Billion Transaction Supporting up to $40B+ of Lending1.4.2026 13:19:00 CEST | Press release
Klarna, the global digital bank and flexible payments provider, has entered into a new capital efficiency transaction in the form of a Significant Risk Transfer (SRT), covering $1.7 billion-worth of Euro denominated loans and freeing up capital to support continued growth. Klarna has entered into a three-year agreement with a consortium led by Värde Partners. This is Klarna's sixth SRT transaction and improves how effectively Klarna deploys its capital on a global basis. "Our banking license is one of our biggest competitive advantages," said Niclas Neglén, Klarna's Chief Financial Officer. "This is our largest and most efficient SRT transaction to date. These transactions allow us to maximize every unit of capital to support our continued momentum." The transaction follows Klarna’s recently announced $2 billion facility supporting $17B of US Financing expansion. About Klarna Klarna is a global digital bank and flexible payments provider. With over 118 million global active Klarna user
Americhem Launches nDryve™: PFAS-Free In-Melt Technology Platform for Functional Fibers1.4.2026 13:00:00 CEST | Press release
Americhem, Inc., a global polymer solutions provider, today announced the launch of nDryve™, a PFAS-free, in-melt surface-modifying technology platform designed to deliver durable multi-fluid repellency against alcohol and other low-surface-energy fluids in fiber systems. As global regulations accelerate the phase-out of per- and polyfluoroalkyl substances (PFAS), manufacturers are under increasing pressure to maintain barrier performance without fluorinated chemistries. nDryve™ was developed to address this shift, offering a PFAS-free, in-melt alternative to conventional surface applied treatments. Engineered for Performance Without PFAS Often referred to as “forever chemicals,” PFAS have come under heightened regulatory scrutiny due to their persistence and potential environmental and health impacts. nDryve™ integrates directly into the polymer during melt processing, embedding surface-modifying functionality within the fiber matrix rather than relying on removable finishes. By engin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
